...
首页> 外文期刊>British Journal of Cancer >Similarity and co-expression of tumour-associated antigens recognised by different monoclonal antibodies
【24h】

Similarity and co-expression of tumour-associated antigens recognised by different monoclonal antibodies

机译:不同单克隆抗体识别的肿瘤相关抗原的相似性和共表达

获取原文

摘要

The concentration of carcinoembryonic antigen (CEA), CA130, CA125, SLX, CA19-9, SPan1, and tumour-associated glycoprotein 72 (TAG-72) in the culture supernatant of 15 cancer cell lines and in the sera of 58 cancer patients was measured, and the co-expression of these antigens was examined by double determinant immunoradiometric assays. The high correlation coefficient of the concentrations and significant binding in the double determinant assays indicated a close relationship between CA125 and CA130 and between CA19-9 and SPan1. There was variable binding of the 125I-labelled anti-SLX, anti-CA19-9, and anti-SPan1 antibodies to anti-CA130 beads that had been pre-incubated with the culture supernatants, suggesting the presence of the epitopes of SLX, CA19-9, and SPan1 on the molecule expressing CA130. Similarly, the epitopes of SLX, CA19-9, and SPan1 could be present on the molecule expressing CEA. 125I-labelled anti-CA19-9, anti-SLX, and anti-TAG-72 antibodies were bound in variable proportions to anti-CA130 beads or to anti-CEA beads that had been pre-incubated with patients' sera. However, CEA and CA130 were not expressed on the same molecule, either in the culture supernatant, or in patients' sera. In conclusion, the carbohydrate epitopes of CA19-9, SPan1, SLX, and TAG-72 could be present on the molecule recognised by the anti-CA130 or anti-CEA antibody; however, the epitopes of CA130 and CEA did not co-exist on the same molecule.
机译:15种癌细胞系的培养上清液和58例癌症患者血清中的癌胚抗原(CEA),CA130,CA125,SLX,CA19-9,SPan1和肿瘤相关糖蛋白72(TAG-72)的浓度为进行测定,然后通过双重确定性免疫放射测定法检查这些抗原的共表达。浓度的高相关系数和双重决定因子分析中的显着结合表明CA125和CA130之间以及CA19-9和SPan1之间存在密切关系。 125I标记的抗SLX,抗CA19-9和抗SPan1抗体与已与培养上清液预孵育的抗CA130珠存在可变结合,表明存在SLX,CA19的表位-9,和表达CA130的分子上的SPan1。同样,SLX,CA19-9和SPan1的表位可能存在于表达CEA的分子上。 125I标记的抗CA19-9,抗SLX和抗TAG-72抗体以可变比例结合至已与患者血清预孵育的抗CA130珠或抗CEA珠。但是,CEA和CA130在培养上清液或患者血清中均未在同一分子上表达。总之,CA19-9,SPan1,SLX和TAG-72的碳水化合物表位可能存在于抗CA130或抗CEA抗体识别的分子上。然而,CA130和CEA的表位不共存于同一分子上。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号